Correlation Between Edify Acquisition and Luckwel Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edify Acquisition and Luckwel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edify Acquisition and Luckwel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edify Acquisition Corp and Luckwel Pharmaceuticals, you can compare the effects of market volatilities on Edify Acquisition and Luckwel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edify Acquisition with a short position of Luckwel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edify Acquisition and Luckwel Pharmaceuticals.

Diversification Opportunities for Edify Acquisition and Luckwel Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Edify and Luckwel is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Edify Acquisition Corp and Luckwel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Luckwel Pharmaceuticals and Edify Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edify Acquisition Corp are associated (or correlated) with Luckwel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Luckwel Pharmaceuticals has no effect on the direction of Edify Acquisition i.e., Edify Acquisition and Luckwel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Edify Acquisition and Luckwel Pharmaceuticals

If you would invest  0.00  in Luckwel Pharmaceuticals on December 29, 2023 and sell it today you would earn a total of  0.00  from holding Luckwel Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Edify Acquisition Corp  vs.  Luckwel Pharmaceuticals

 Performance 
       Timeline  
Edify Acquisition Corp 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Edify Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Edify Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Luckwel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Luckwel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Luckwel Pharmaceuticals is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Edify Acquisition and Luckwel Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edify Acquisition and Luckwel Pharmaceuticals

The main advantage of trading using opposite Edify Acquisition and Luckwel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edify Acquisition position performs unexpectedly, Luckwel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Luckwel Pharmaceuticals will offset losses from the drop in Luckwel Pharmaceuticals' long position.
The idea behind Edify Acquisition Corp and Luckwel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities